Clinical Trials

Ongoing Clinical Trials

Clinical Trials Currently Recruiting Patients:

Dermatology Research Registry 

If you are interested in possibly participating in any of our current or future research studies, please sign up for our Dermatology Research Registry online at: https://unc.az1.qualtrics.com/jfe/form/SV_e2oTA4coH0gGvuR

Your information will be kept confidential and will only be used to contact you about potential research studies.  Your information will not be shared.

 

Seeking Patients with Plaque Psoriasis to participate in a comparison study of a new Investigational Lotion to Ultravate cream, or placebo lotion or cream.

Requirements: Subjects must be 18 years or older with plaque psoriasis. Be in general good health and willing to stop other psoriasis treatments.

Duration: 2Weeks of treatment. There will be up to 3 study visits over a 3-7 week period at UNC Dermatology.

Details: Subject compensation available. Study medication and study-related exams will be provided at no cost.
Sponsor: Valeant Pharmaceuticals
For more information, please contact:

Laura Keck

Study Coordinator

UNC Dermatology and Skin Cancer Center

984-974-3682

lmcleod@email.unc.edu

 

Pediatric Psoriasis Research Study (Topical Medication)


Requirements: Pediatric patients (2-11 years) with mild to moderate plaque type psoriasis affecting the body and scalp.  Additional treatments other than the study medication are not permitted during the study period.  
Duration: 4 total visits, 2 week screening period, 8 week treatment period, plus a follow-up phone call one week after the last study visit.
Incentive: Subject compensation available.  Study medication, study-related exams, and lab tests will be provided at no cost. 

 

Sponsor: Supported by Stiefel, a GSK company

 

For more information please contact:    Lauren Brown
                                                                    984-974-3682
                                                                    
brownln@email.unc.edu

 

 

Adult Atopic Dermatitis (Eczema) Study (Oral Medication)

Requirements: Subjects over 18 years old with active atopic dermatitis (eczema) and itching associated with eczema.

Duration: Approximately 3 months with a 9-week dosing period and 11 study visits.

Incentive: Subject compensation available for time and travel. Study medication, study-related exams, and lab tests will be provided at no cost.

Sponsor: Tioga Pharmaceuticals

For more information, please contact:       Laura Keck

                                                                        984-974-3682

                                                                        lmcleod@email.unc.edu

 

Your Physician:
Aida Lugo-Somolinos, MD
Link to Dr. Lugo-Somolinos' Research